Skip to content

A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism

A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000528651
Enrollment
12
Registered
2005-09-26
Start date
2005-04-05
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Testosterone Metered Dose (MD) Lotion, single dose.

Sponsors

Acrux DDS Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy volunteers

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026